Puma Biotechnology
PBYI
PBYI
137 hedge funds and large institutions have $2.61B invested in Puma Biotechnology in 2014 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.41% less ownership
Funds ownership: 83.84% → 83.44% (-0.41%)
16% less call options, than puts
Call options by funds: $13.7M | Put options by funds: $16.4M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
137
Holding in Top 10
2
Calls
$13.7M
Puts
$16.4M
Top Buyers
| 1 | +$38.8M | |
| 2 | +$34M | |
| 3 | +$18.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$14.3M |
Top Sellers
| 1 | -$59.8M | |
| 2 | -$41.5M | |
| 3 | -$12.2M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$6.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.5M |